Skip to content
10-K

Annual Report

Genprex, Inc. GNPX

0001437749-26-010346

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 9.04M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$15.31M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$17.92M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.83M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.6M
Stockholders Equity FY 2025 · Dec 31, 2025 $7.96M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.62M
Stockholders Equity FY 2025 · Dec 31, 2023 $7.42M
Current Liabilities FY 2025 · Dec 31, 2025 $2.17M
Current Liabilities FY 2025 · Dec 31, 2024 $2.5M
Total Liabilities FY 2025 · Dec 31, 2025 $2.2M
Total Liabilities FY 2025 · Dec 31, 2024 $2.5M
Current Assets FY 2025 · Dec 31, 2025 $8.36M
Current Assets FY 2025 · Dec 31, 2024 $2.08M
Total Assets FY 2025 · Dec 31, 2025 $10.16M
Total Assets FY 2025 · Dec 31, 2024 $4.12M
Eps Basic FY 2025 · Dec 31, 2025 −$17.40
Eps Basic restated FY 2025 · Dec 31, 2024 −$266.89
Sga Expense FY 2025 · Dec 31, 2025 $6.09M
Sga Expense FY 2025 · Dec 31, 2024 $10.63M
Rd Expense FY 2025 · Dec 31, 2025 $9.43M
Rd Expense FY 2025 · Dec 31, 2024 $10.54M
Net Income FY 2025 · Dec 31, 2025 −$16.23M
Net Income FY 2025 · Dec 31, 2024 −$21.11M
Operating Income FY 2025 · Dec 31, 2025 −$15.52M
Operating Income FY 2025 · Dec 31, 2024 −$21.17M